Sucralfate is a drug used in the treatment of gastric and duodenal ulcer; it is cytoprotective and able to increase the bioavailability of several growth factors, modulating the wound healing process. In this study we tested the possible therapeutic effect of Sucralfate in the treatment of ulcerative lesion occurring in uterine cervix; to investigate such effect we used an experimental rat model of cervicitis in which the uPAR and EGFR expression were evaluated. Cervicitis was induced in wild and ovariectomized wistar female rats by an acetic acid-soaked tampon. The animals were divided into two main groups (4 and 7 days) and Sucralfate was administered topically until the day they were sacrificed. In order to distinguish physiological and drug-induced healing, quantitative and qualitative uPAR and EGFR expression were evaluated by using Western Blot and Immunohistochemistry techniques. Western Blot analysis demonstrated an increased expression of both receptors after 4 days from wounding in wild and ovariectomized animals. In particular in ovariectomized animals the expression of uPAR and EGFR increased after 4 days while it reduced following the administration of Sucralfate. In wild rats the same was observed for uPAR expression, while EGFR was different; in fact, its expression increased significantly at day 4 in the animals treated with the drug and only at day 7 in those untreated. Immunohistochemistry highlighted a noteworthy epithelial colocalization of EGFR and uPAR after 4 days in the animals treated with Sucralfate. We conclude that Sucralfate can promote the healing of ulcerative cervicitis and moreover, it reduces the normal healing time because of its modulatory property on uPAR and EGFR expression.
Sucralfate is a drug used in the treatment of gastric and duodenal ulcer; it is cytoprotective and able to increase the bioavailability of several growth factors, modulating the wound healing process. In this study we tested the possible therapeutic effect of Sucralfate in the treatment of ulcerative lesion occurring in uterine cervix; to investigate such effect we used an experimental rat model of cervicitis in which the uPAR and EGFR expression were evaluated. Cervicitis was induced in wild and ovariectomized wistar female rats by an acetic acid-soaked tampon. The animals were divided into two main groups (4 and 7 days) and Sucralfate was administered topically until the day they were sacrificed. In order to distinguish physiological and drug-induced healing, quantitative and qualitative uPAR and EGFR expression were evaluated by using Western Blot and Immunohistochemistry techniques. Western Blot analysis demonstrated an increased expression of both receptors after 4 days from wounding in wild and ovariectomized animals. In particular in ovariectomized animals the expression of uPAR and EGFR increased after 4 days while it reduced following the administration of Sucralfate. In wild rats the same was observed for uPAR expression, while EGFR was different; in fact, its expression increased significantly at day 4 in the animals treated with the drug and only at day 7 in those untreated. Immunohistochemistry highlighted a noteworthy epithelial colocalization of EGFR and uPAR after 4 days in the animals treated with Sucralfate. We conclude that Sucralfate can promote the healing of ulcerative cervicitis and moreover, it reduces the normal healing time because of its modulatory property on uPAR and EGFR expression.
Cervicitis is an inflammatory phenomenon that occurs at uterine cervix level through trauma or infectious events.
The main aim of this study is to investigate the possible role of Sucralfate in cervicitis treatment. Sucralfate is a well-known drug used in treatment of gastric and duodenal ulcer; it has cytoprotective effects not only by forming a physical barrier (1), but also by protecting several growth factors from proteolytic degradation (2) .
Interestingly, Sucralfate has been also used in clinical treatment of vaginal ulceration (Lentz SS, 1993) , however no experimental work has been published to demonstrate its effectiveness in reproductive diseases.
Ulcer healing is controlled by growth factor, such as EGF and bFGF, hormones and cytokines (3) (4) , as well as by a large amount of molecules with adhesive and signalling roles, for instance, receptors like EGF receptor (EGFR) and urokinase plasminogen Activator Receptor (uPAR) (5) (6) . These receptors also enhance the cellular proliferation and migration typical of wound healing processes (7) (8) .
In particular, uPAR is involved in the activation of the urokinase-and tissutal-Plasminogen Activator (uPA, tPA); the binding of PA to uPAR triggers a further cascade of events leading to cell adhesion, migration and growth within the extracellular matrix (ECM) (9-I I).
In the wounded area EGFR is expressed during all the healing steps; in fact Repertinger et al. showed that EGFR null mice have delayed wound closure compared to wild type mice, which significantly showed a greater microvessel density 3 days after wounding (12) .
The aim of our study is to test a new application of Sucralfate's cream in treatment of cervicitis in an experimental animal model using ovariectomized (OVX) and non-ovariectomized wistar female rats.
It was decided to introduce ovariectomized groups because the clinical treatment of cervical lesion occurring during the menopause period could result more difficult because of the estrogen reduction: in fact estrogen (E2) contributes to enhance the wound healing process in OVX rodents (13) as well as in elderly humans (14) .
MATERIALS AND METHODS

Experimental model ofcervicitis
On the basis of experimental models of gastric ulcer induced by acetic acid (15), we tested acetic acid at different exposure times to induce cervical lesion on 21 animals. After anaesthesia with Chloral hydrate (300 mg/kg p.c., Carlo Erba, Milan, Italy), cervical lesion was induced with a Glacial Acetic acid-soaked (I 00 ul, Carlo Erba, Milan, Italy) tampon introduced for 30,60 and 120 seconds in animals. The animals were then sacrificed after 4, 7 and 14 days: the lesion entity and the physiological healing time were observed with both stereotaxic and optic microscope. We concluded that 30 sec were sufficient to induce an ulcerative cervicitis, which healed spontaneously in two weeks (Fig. I) .
The effectiveness of Sucralfate was then tested in a study conducted on 60 Wistar (Harlan, Italy) female rats (200±20 g), all healthy adults. They were divided into six different experimental groups consisting of: I. Control animals (C); 2. Animals with cervical lesion (L): sacrificed after 4 days (L4) and 7 days (L7); 3. Animals with cervical Icsion treated with Sucralfate (LS): sacrificed after 4 days (LS4) and 7 days (LS7); 4. OVX animals (OC) ; 5. OVX animals with cervical lesion (OL): sacrificed after 4 days (OL4) and 7 days (OL7); 6. OVX animals with cervical lesion treated with Sucralfate (OLS): sacrificed after 4 'days (OLS4) and 7 days (OLS7).
Surgery
Animals were anesthetized with Chloral hydrate (300 mg/kg p.c., Carlo Erba, Milan, Italy) prior to surgery. Bilateral ovariectomies were performed by making a ventral midline incision inferior to the palpated rib cage and kidneys with standard aseptic technique. Briefly, ovaries were exposed and part of the fallopian tube tied off with silk suture. Ovaries and oviducts were separated from the fat pouch, the oviducts were cut and the ovaries and fallopian tubes were removed. The peritoneal cavity was closed with cat-gut suture, and skin was closed with silk suture. All animals received antibiotic treatmend for 5 days following the surgery.
Cervical lesion and treatment
After anaesthesia, cervical lesion was induced using a Glacial Acetic acid-soaked tampon introduced in the animals for 30 seconds; the animals treated with drugs received a topical and daily application of a salve (50 ul) with 12% Sucralfate (Fannigea S.p.a., Italy) until the day they were sacrificed.
The experimental protocol was followed in compliance with the guidelines of the local Ethics Committee.
Western Blotting
Cervices were homogenized in lysis buffer (10 mM Tris-HCI, pH 7.4, 150 mM NaCl, 1% Nonidet P-40 0.1%, ImM EDTA, and a protease inhibitor mixture [Roche Molecular Biochemicals]).
Samples were size-fractionated on a 6% (for EGFR detection) or 8% (for uPAR detection) SDS-PAGE gel and electrotransferred to a nitocellulose membrane (BIO-RAD Laboratories). The membrane was blocked in 5% non-fat milk in PBST (PBS with O. I% Tween 20) for I h at room temperature and then incubated overnight with the primary antibody (rabbit polyclonal IgG anti-uPAR (FL-290), rabbit polyclonal IgG anti-EGFR (1005) (Santa Cruz, California, USA). The membranes were washed and incubated with HRP-conjugated goat anti-rabbit IgG antibody for 2 hr at room temperature. The signal was visualized by an enhanced chemiluminescence solution (Super Signal, Pierce, USA) and intensity evaluated with specific software (Kodak ID 3.6 ).
Immunohistochemistry
Immunohistochemistry for uPAR and EGFR was carried out with a commercial Kit (Zymed Histornouse, California, USA) following the manufacturer's protocol. In brief, paraffin sections were pre-treated with xylene and then incubated with trypsin for 10 minutes at 37°C. Sections were incubated overnight at 4°C with the primary antibody (rabbit polyclonal IgG anti-uPAR (FL-290), rabbit polyclonal IgG anti-EGFR (1005), Santa Cruz, California, USA). The sections were then washed with PBS and incubated with biotinylated secondary antibody, and finally with Streptavidin-peroxidase conjugate. The signal was developed using the AEC substrate for peroxidase.
Data were expressed as incremental change vs baseline, and the statistical analysis was performed using Statsoft's STATISTICA program. One-way ANaYA was calculated and the Student-Newmann-Keuls test was used for multiple comparisons, considering differences with p<0.05 significant. RESULTS
Western Blot analysis EGFR expression:
The acetic acid-soaked tampon induced a significant increase in EGFR tissutal level in wild female rats (Fig 2A) In Fig. 28 the data concerning the EGFR espression in OVX animals is reported. Analysis of variance did not show any significant difference between OVX control (OC: 1OO±5) and wild control (C: 172±22). Differently from wild females with cervicitis at day 4, OVX females with cervicitis did not enhance the EGFR expression at the 4 th day; however, Sucralfate treatment modulated EGFR expression, in fact the OLS4 group showed a significant increase in EGFR tissutal levels in respect to OVX control (OLS4: 216±32 p<O.05 vs OC: IOO±5 ); in not-treated animals the increasing EGFR expression in the OL7 group was significant in respect to both controls and OLS7 groups (OL7: 288±22 p<O.05 vs C: I 72±22 OC: 100±5 and OLS7: I 55±26). uPAR expression: As reported in Fig. 3A , uPAR level increased significantly in both L4 (l65±3) and L7 (l51±2) groups in respect to controls (p<O.05).
Furthermore, it was observed that at the same time, after the lesion, the increase of uPAR levels was enhanced in the groups treated with Sucralfate; in fact LS4 increase was significant in all the experimental groups (LS4: 256±3 p<O.O I vs C: IOO±l and p<O.05 vs L4: 165±3, L7: 151±2, LS7: 176±2); at day 7, the Sucralfate-treated animals (LS7) presented less tissutal content than the group treated for 4 days (LS4), even though greater than controls (LS7: I 76±2 p<O.05 vs LS4: 256±3 and C: lOO±l).
After ovariectomy surgery (Fig. 3B) , basal
Fig. 4. EGFR Immunohistochemistry (40x): (A)
Ovariectomized Control (OC) ; (B) Ovariectomized rats with cervical lesion at day 4 (OL4); (C) Ovariectomized rats with cervical lesion and treated with Sucralfate at day 4 (OLS4). EGFR expression increased after wounding in the subepithelial level after 4 days (B), while following the treatment with Sucralfate, an increased EGFR expression can be observed at epithelial levels (C).
uPAR expression was quite similar to the wild control. Lesive event significantly increased uPAR expression after 4 (OL4) and 7 days (OL 7) from wounding in respect to both controls (OL4: I99±28, . OL7: I78±9, p<O.05 vs C: I24±5 and OC: IOO±30). uPAR tissutal level in the group treated with the drug for 4 days, even if it did not differ from OL4, significally increased not only in respect to both controls (C and OC), but also in respect to the OL7 and OLS7 groups (OLS4: 233±25 p<O.05 vs C: I24±5, OC: IOO±30, OL 7: 178±9 and OLS7: l23±20). Finally, a significant decreasing was also Immunohistochemistry results EGFR localization: The photos in Fig. 4 report the antibody localization in specimen from animals of OL4 and OLS4 groups. In accordance with Western Blot data, the differences between the lesioned groups were more evident in the early phases of the healing.
Immunohistochemistry analysis for EGFR showed an increased expression of this receptor after wounding, more marked in the subepithelial level after 4 days (Fig. 4B) . Following the treatment with Sucralfate, EGFR showed a similar expression at epithelial levels, while it was quite absent in the inner layers (Fig. 4C) .
uPAR localization : Immunoistochemistry analysis for uPAR presented the same EGFR distribution after 4 days from wounding in both OL4 and OLS4 groups; this result was shown in Fig 5 where the same tissue specimen was incubated with EGFR antibody (Fig. 5A ) and uPAR antibody (Fig.  58) .
EGFR and uPAR localizations in nonovariectomized animals were the same as of those found in OVX animals (data not shown).
DISCUSSION
Sucralfate has been used for a long time in the treatment of gastric or duodenal ulcers. In acid pH conditions, Sucralfate creates a polyanionic gel that binds the proteins of the ulcer crater and protects several growth factors from acid proteolytic degradation (I), increasing their bioavailability (16) .
Interestingly, even if Sucralfate increases gastric ulcer healing, it does not affect the PGE2 levels (17) (18) which have a central role in gastric ulcer healing trough the activation of EP4 receptor (19) . PGE2 is important in the cervical ripening, however it can be differently modulated by the presence/ absence of oestrogens (20) . To avoid hormones or other modulators in the effectiveness of Sucralfate treatment in wound repair, we used both whole and OVX animals.
Recently Sucralfate has been also used for reducing postoperative pain and promoting wound healing after open hemorrhoidectomy (21) , for the healing of burns or skin injuries (22) and in the clinical treatment of vaginal ulceration (23) .
This study investigates the effectiveness of Sucralfate in cervicitis healing, focusing attention on uPAR and EGFR expression, because of their involvement in tissue repair.
Recently a possible cooperation between these two receptor systems was suggested (24) (25) (26) : it is well known that even if uPAR is lacking in transmembrane and cytoplasmatic domain (27) , it has a complicated signaling pathway, activating Ras and MAP kinases (28) . Liu et al. identified a complex that includes uPAR, a5~J integrins and EGFR: after the binding ofuPAR with uPA, focal adhesion kinase operated downstream of a5~1 integrins to activate EGFR, and extracellular signal-regulated kinase (ERK) pathway (29) . Furthermore, Jo M. et al. demonstrated that EGFR may act as a transducer of the uPAR signal to the extracellular signal-regulated kinase (ERK) (28) .
Finally, Guerrero et al. showed that uPAR induces the transactivation of EGFR, which leads to ERK activation in cells with a normal expression of uPAR receptor (24) .
In our experimental rat model of cervicitts, Western blot analisys revealed that uPAR levels increased after the Sucralfate treatment in OVX and wild rats, in respect to controls and an untreated group. The increase of uPAR in the 4 day-treated group could be a key element to induce the ECM degradation and the release of growth factors, facilitating the repair process. After 7 days of drug treatment a decreasing of this receptor was evident, in accordance with the advanced state of healing; a similar development was also demonstrated for EGFR levels in animals treated with Sucralfate.
Furthermore, in OVX animals, Western blot analysis showed a significant increase of tissue levels of EGFR after 4 days only in OLS4, while in the untreated group EGFR expression increased only 7 days after the lesion (OL 7).
The role of EGFR in mediating biological properties of Sucralfate was described by Tarnawski et al. (30) . Recently it was demonstrated that EGFR also induces angiogenesis in murine skin carcinomas and other neoplasms, suggesting the ability ofEGFR to accelerate blood vessel formation during wound healing (12) .
Our results show that Sucralfate had an effect in accelerating the healing process occurring during cervicitis by inducing a precocious increase of tissutal receptor content.
In fact, uPAR and EGFR expression in OLS-7 rats did not differ from controls (C and OC), even if it was reduced in respect to OL-4, OL-7 and OLS-4 rats. It should be taken into consideration that in uterine cervix the receptor induction could be modulated by inflammation by the presence of sexual hormone and by drug treatment:
In wild rats with cervicitis treated with the drug the receptor expression did not decrease at day 7, probably because of the additive proliferating and migration stimulus by estrogen and drug presence.
In a different way, in OVX rats the induction of uPAR and EGFR expression was caused only by lesion and drug; in fact, both ulcerative stimulus and Sucralfate application enhances growth factor release; ulcer healing is associated with a reduction of growth factor levels and consequently with a reduced expression of both the receptors. Thus, the reduced healing time observed in OVX rats receiving Sucralfate could explain the reduction of uPAR and EGFR which was observed after 7 days.
Finally, uPAR and EGFR immunohistochemistry analysis showed a similar qualitative and timedepending localization of both receptors at subepithelial level after 4 days from lesion, while in rats treated with Sucralfate they were especially expressed on epithelial level. These results are in agreement with previous works, which demonstrate the existence of a common pathway of the two receptors (24, 26, 29) .
In conclusion, all our data suggest that vaginal administration of Sucralfate in wild and OVX female wistar rats improves ulcer healing. It is noteworthy that the present study shows a novel application of Sucralfate as a topic drug in cervical ulceration repair. It also suggests the existence of a synergic activity of uPAR and EGFR as a mechanism trigged by the presence of Sucralfate..
We hypothesize that Sucralfate, protecting the cervix mucosal layer, increases the bioavaiability of several growth factors, such as bFGF and HB-EGF, which could lead to a precocious and transient increased expression ofuPAR and EGFR.
